1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. 1974; A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 54:271–6. PMID:
4153258.
2. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. 2017; Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 135:e927–99. DOI:
10.1161/CIR.0000000000000484. PMID:
28356445.
Article
4. de Godoy MF, Takakura IT, Machado RD, Grassi LV, Nogueira PR. 2007; Serum ferritin and obstructive coronary artery disease: angiographic correlation. Arq Bras Cardiol. 88:430–3. DOI:
10.1590/S0066-782X2007000400011. PMID:
17546273.
5. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. 1992; High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 86:803–11. DOI:
10.1161/01.CIR.86.3.803. PMID:
1516192.
Article
6. Takahara T, Shimizu M, Nakagishi Y, Kinjo N, Yachie A. 2015; Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease. Rheumatol Int. 35:81–4. DOI:
10.1007/s00296-014-3059-2. PMID:
24917023.
Article
7. Yamamoto N, Sato K, Hoshina T, Kojiro M, Kusuhara K. 2015; Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy. Mod Rheumatol. 25:898–902. DOI:
10.3109/14397595.2015.1038430. PMID:
25849851.
Article
8. Mizuta M, Shimizu M, Inoue N, Kasai K, Nakagishi Y, Takahara T, et al. 2016; Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease. Mod Rheumatol. 26:929–32. DOI:
10.3109/14397595.2016.1159120. PMID:
27433933.
Article
10. Ackerman Z, Pappo O, Ben-Dov IZ. 2011; The prognostic value of changes in serum ferritin levels during therapy for hepatitis C virus infection. J Med Virol. 83:1262–8. DOI:
10.1002/jmv.22093. PMID:
21567428.
Article
11. Soepandi PZ, Burhan E, Mangunnegoro H, Nawas A, Aditama TY, Partakusuma L, et al. 2010; Clinical course of avian influenza A (H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008. Chest. 138:665–73. DOI:
10.1378/chest.09-2644. PMID:
20507944. PMCID:
PMC7094603.
12. Chaiyaratana W, Chuansumrit A, Atamasirikul K, Tangnararatchakit K. 2008; Serum ferritin levels in children with dengue infection. Southeast Asian J Trop Med Public Health. 39:832–6. PMID:
19058577.
13. Kawamata R, Yokoyama K, Sato M, Goto M, Nozaki Y, Takagi T, et al. 2015; Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for
Mycoplasma pneumoniae pneumonia. J Infect Chemother. 21:783–9. DOI:
10.1016/j.jiac.2015.07.009. PMID:
26298038.
14. Shin S, Oh J, Park H. 2021; Comparison of three blood collection tubes for 35 biochemical analytes: the Becton Dickinson Barricor Tube, serum separating tube, and plasma separating tube. Ann Lab Med. 41:114–9. DOI:
10.3343/alm.2021.41.1.114. PMID:
32829587. PMCID:
PMC7443522.
Article
15. Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, et al. 2009; Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol. 30:810–17. DOI:
10.1007/s00246-009-9441-2. PMID:
19365652.
Article
16. Lee H, Kim H, Kim HS, Sohn S. 2006; NT-pro BNP: a new diagnostic screening tool for Kawasaki disease. Korean J Pediatr. 49:539–44. DOI:
10.3345/kjp.2006.49.5.539.
17. Lee DW, Kim YH, Hyun MC, Kwon TC, Lee SB. 2010; NT-proBNP as a useful tool in diagnosing incomplete Kawasaki disease. Korean J Pediatr. 53:519–24. DOI:
10.3345/kjp.2010.53.4.519.
Article
18. Guo L, Jiang F, Tang YT, Si MY, Jiao XY. 2014; The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease. Diabetes Technol Ther. 16:224–34. DOI:
10.1089/dia.2013.0181. PMID:
24279470. PMCID:
PMC3952528.
Article
19. Ohno T, Yuge T, Kariyazono H, Igarashi H, Joh-o K, Kinugawa N, et al. 2002; Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr. 161:105–11. DOI:
10.1007/s00431-001-0860-1. PMID:
11954744.
Article